Insulin-like plant proteins as potential innovative drugs to treat diabetes-The Moringa oleifera case study

N Biotechnol. 2017 Oct 25;39(Pt A):99-109. doi: 10.1016/j.nbt.2016.10.005. Epub 2016 Oct 11.

Abstract

Various plant species have long been used in traditional medicine worldwide to treat diabetes. Among the plant-based compounds with hypoglycemic properties, studies on insulin-like proteins isolated from leaves, fruits and seeds are rarely reported in the relevant literature. Our research group has been investigating the presence of insulin-like proteins in Moringa oleifera, a plant species native to India, and we have obtained a leaf protein isolate and semi-purified derived fractions, as well as a seed coat protein fraction (Mo-SC), with hypoglycemic activity in chemically induced diabetic mice that have increased tolerance to orally administered glucose. Equally importantly, Mo-SC possesses insulin-like antigenic epitopes. In this context, the present review aims to highlight that prospection of insulin-like proteins in plants is of the utmost importance both for finding new drugs for the treatment of diabetes and for shedding light on the mechanisms involved in diabetes.

Keywords: Diabetes therapy; Hypoglycemic protein; Insulin-like plant protein; Moringa; Prospection.

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Diabetes Mellitus / drug therapy*
  • Humans
  • Insulin / chemistry
  • Insulin / isolation & purification
  • Insulin / therapeutic use*
  • Lectins / therapeutic use
  • Moringa oleifera / chemistry*
  • Plant Leaves / chemistry
  • Plant Proteins / chemistry
  • Plant Proteins / isolation & purification
  • Plant Proteins / therapeutic use*

Substances

  • Insulin
  • Lectins
  • Plant Proteins